Investors may be interested in viewing the Gross Margin score on shares of Eli Lilly and Company (NYSE:LLY). The name currently has a score of 19.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.  The low score of 19.00000 for Eli Lilly and Company indicates a top score for stability and growth.

Investors might be trying to figure out how to play the stock market at current levels. The optimist may see much more upward action in the future while the pessimist may be waiting for the impending disaster. Buying into the market at these levels will no doubt come with a bit of caution. Even at these levels, there may still be some good buys. The average individual investor may need to spend a little more time doing the homework, but it may pay off handsomely if the stock market decides to break out higher. As companies start to report quarterly earnings, investors will be watching to see what types of trends emerge. A generally upbeat earnings season may give the bulls more strength to breakout and continue the charge higher into the later stages of the year.  

At the time of writing, Eli Lilly and Company (NYSE:LLY) has a Piotroski F-Score of 8. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.

C Score (Montier)

The C-Score is a system developed by James Montier that helps determine whether a company is involved in falsifying their financial statements. The C-Score is calculated by a variety of items, including a growing difference in net income verse cash flow, increasing days outstanding, growing days sales of inventory, increasing assets to sales, declines in depreciation, and high total asset growth. The C-Score of Eli Lilly and Company (NYSE:LLY) is 2.00000. The score ranges on a scale of -1 to 6. If the score is -1, then there is not enough information to determine the C-Score. If the number is at zero (0) then there is no evidence of fraudulent book cooking, whereas a number of 6 indicates a high likelihood of fraudulent activity. The C-Score assists investors in assessing the likelihood of a company cheating in the books.

Eli Lilly and Company (NYSE:LLY) has a current ERP5 Rank of 7502 . The ERP5 Rank may assist investors with spotting companies that are undervalued. This ranking uses four ratios. These ratios are Earnings Yield, ROIC, Price to Book, and 5 year average ROIC. When looking at the ERP5 ranking, it is generally considered the lower the value, the better.

Shifting gears, we can see that Eli Lilly and Company (NYSE:LLY) has a Q.i. Value of 40.00000. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be.

Doing the proper research can go a long way when preparing to enter the stock market. Professional investors typically make sure that all the necessary research is completed when making crucial decisions. Of course, all the research in the world cannot guarantee success in the markets, but it can help to keep the investor one step ahead of the class. Understanding how the stock market functions can help the investor gain the confidence to start conquering the terrain. Building confidence in investing decisions can play a big part in the future success of the individual’s portfolio.  

Checking in on some valuation rankings, Eli Lilly and Company (NYSE:LLY) has a Value Composite score of 63. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 50.

Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow.  The FCF Growth of Eli Lilly and Company (NYSE:LLY) is 0.176376.  Free cash flow (FCF) is the cash produced by the company minus capital expenditure.  This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends.  The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow.  The FCF Score of Eli Lilly and Company (NYSE:LLY) is 0.803352.  Experts say the higher the value, the better, as it means that the free cash flow is high, or the variability of free cash flow is low or both.

There are plenty of various strategies to employ when deciding which stocks to buy. These different strategies may be super simple or highly complex. Although there is no one plan that will magically create instant profits, having a plan in place will most likely benefit the investor immensely. One way to examine shares is by following fundamental data. Essentially, fundamental study involves viewing the health of a particular company by studying company financials. Many investors will closely study the balance sheet to see how profitable the company has been and try to figure out future performance. Investors may choose to compare companies that share the same sector in order to get a truer sense of how it stacks up to the competition.

Price Index

The Price Index is a ratio that indicates the return of a share price over a past period. The price index of Eli Lilly and Company (NYSE:LLY) for last month was 0.91386. This is calculated by taking the current share price and dividing by the share price one month ago. If the ratio is greater than 1, then that means there has been an increase in price over the month. If the ratio is less than 1, then we can determine that there has been a decrease in price. Similarly, investors look up the share price over 12 month periods. The Price Index 12m for Eli Lilly and Company (NYSE:LLY) is 1.52876.
Price Range 52 Weeks

Some of the best financial predictions are formed by using a variety of financial tools. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks. The Price Range of Eli Lilly and Company (NYSE:LLY) over the past 52 weeks is 0.902000. The 52-week range can be found in the stock’s quote summary.

Investors might be searching far and wide for the next set of winning stocks to add to the portfolio. Many value investors may be on the lookout for stocks that are underpriced at current levels. Some investors may be looking for names that have the potential to see major growth in the next few years. Picking growth companies can be a bit riskier, but they may have much bigger potential for substantial returns. Other investors may be interested in finding companies that provide stable returns and pay out a solid dividend. Investors may even choose to piece together the portfolio with stocks from different categories. Having a diverse selection of stocks is typically recommended for longer-term portfolio health.